[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

First-Time Generics- March 2004

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 AMOXICILLIN & CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, US 600 MG/42.9 MG (BASE)/5 ML TEVA PHARMACEUTICALS USA AUGMENTIN ES-600 FOR ORAL SUSPENSION 3/12/2004
2 DEFEROXAMINE MESYLATE FOR INJECTION, USP 500 MG/VIAL AND 2 G/VIAL ABBOTT LABORATORIES DESFERAL FOR INJECTION 3/17/2004
3 NAPROXEN SODIUM & PSEUDOEPHEDRINE HCL EXTENDED-RELEASE TABLE 200 MG (BASE)/120 MG L. PERRIGO COMPANY ALEVE COLD AND SINUS EXTENDED-RELEASE TABLETS 3/17/2004
4 HYDROCODONE BITARTRATE AND IBUPROFEN TABLETS 5 MG/200 MG INTERPHARM, INC. VICOPROFEN TABLETS 3/18/2004
5 BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, USP 150 MG (TWICE-A-DAY DOSING) EON LABS, INC. WEBBBUTRIN SR TABLETS 3/22/2004
6 DEMECLOCYCLINE HYDROCHLORIDE TABLETS, USP 150 MG AND 300 MG IMPAX LABORATORIES, INC. DECLOMYCIN HYDROCHLORIDE TABLETS 3/22/2004
7 NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) CAPSULES 100 MG MYLAN PHARMACEUTICALS, INC. MACROBID CAPSULES 3/22/2004
8 BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, USP 150 MG (TWICE-A-DAY DOSING) IMPAX LABORATORIES, INC. WELLBUTRIN SR SUSTAINED-RELEASE TABLETS 3/22/2004
9 NIFEDIPINE EXTENDED-RELEASE TABLETS, USP 90 MG MARTEC SCIENTIFIC, INC. PROCARDIA XL 90 MG 3/23/2004
10 OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS 10 MG, 20 MG, AND 40 MG ENDO PHARMACEUTICALS, INC. OXYCONTIN EXTENDED-RELEASE TABLETS 3/23/2004
11 OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS 80 MG TEVA PHARMACEUTICALS USA OXYCONTIN EXTENDED-RELEASE TABLETS 3/23/2004
12 ERYTHROMYCIN AND BENZOYL PEROXIDE TOPICAL GEL, USP 3%/5% ATRIX LABORATORIES, INC. BENZAMYCIN TOPICAL GEL 3/29/2004
13 MICONAZOLE NITRATE CREAM 4% & MICONAZOLE NITRATE CREAM 2% 4%/2% (COMBINATION PACKAGE) (OTC) L. PERRIGO COMPANY MONISTAT 3 COMBINATION PACK 3/30/2004
14 QUINAPRIL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE TABLETS 10 MG (BASE)/12.5 MG, 20 MG (BASE)/12.5 MG, AND 20 MG (BASE)/25 MG AMIDE PHARMACEUTICAL, INC. ACCURETIC TABLETS 3/31/20

Back to Top     Back to Approvals

Date created: April 5, 2004

horizonal rule